WHO ICTRP trial
A clinical trial evaluating the safety, tolerability, and efficacy of high…
ChiCTR1900024259 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR1900024259 |
|---|---|
| Public title | A clinical trial evaluating the safety, tolerability, and efficacy of high intensity focused ultrasound therapy (HIFU) in patients with (primary and secondary) liver cancer |
| Scientific title | A clinical trial evaluating the safety, tolerability, and efficacy of high intensity focused ultrasound therapy (HIFU) in patients with (primary and secondary) liver cancer |
| Primary sponsor | HwaMei Hospital, University of Chinese Academy of Sciences |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | 1-2 |
| Countries | China |
| Conditions | Primary and secondary liver cancer |
| Interventions | Case series:HIFU treatment |
| Registration date | Jul 3, 2019 |
| Target size | Case series:100 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: